35 Participants Needed

3D Kidney Model Education for Kidney Disease

AR
Overseen ByAfiel R da Silva, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Hilary L Surratt, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the 3D Kidney Model treatment for kidney disease?

Research shows that 3D models help patients and doctors better understand kidney anatomy and conditions, which can improve education and treatment planning for kidney disease.12345

How is the 3D Kidney Model treatment different from other treatments for kidney disease?

The 3D Kidney Model treatment is unique because it uses three-dimensional models to help patients better understand their kidney anatomy and disease, which can improve education and comprehension compared to traditional methods that rely on two-dimensional images.13678

What is the purpose of this trial?

High blood pressure has a different rate effect on many minoritized individuals. African Americans, as a result of high blood pressure, are six times more likely to go through kidney failure compared to white counterparts. Hispanic communities are also disproportionately affected by high blood pressure and, unfortunately, generally have lower knowledge about the effects on the kidneys as well. Unfortunately, many minoritized and underserved communities are affected by the weight of the social determinants of health, i.e., housing, education, food, health care, etc., that contribute to large disparities in health outcomes. These factors lead to poor care management, less ability to manage care effectively, and disengagement from care. Health education is vital to recognizing and communicating with minoritized patients with hypertension-induced chronic renal disease. As the patient's knowledge of the condition grows, this can significantly influence the trust between clinicians and patients. Effective and patient-centered education can inspire patients to be proactive in their prevention strategies with clinicians. This study's overall goal is to assess the utility of a novel patient education tool (3D-printed healthy kidney and diseased kidney models) in optimizing patient education for underserved populations who have hypertension with a potential lead to hypertension-induced chronic renal disease.

Research Team

HL

Hilary L Surratt, PhD

Principal Investigator

University of Kentucky

Eligibility Criteria

This trial is for individuals from minoritized communities with high blood pressure that may lead to chronic kidney disease. It aims to educate those who might not have extensive knowledge about the impact of hypertension on kidneys, focusing on African American and Hispanic populations affected by health disparities.

Inclusion Criteria

Seeking medical care in study location
I have high blood pressure and kidney disease.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive patient education using either standard clinician-led methods or the 3D kidney model

1 hour
1 visit (in-person)

Follow-up

Participants are monitored for changes in understanding and confidence in managing kidney disease

4 weeks

Treatment Details

Interventions

  • 3D Kidney Model
Trial Overview The study is testing a new patient education tool: 3D-printed models of healthy and diseased kidneys. Participants will receive standard medical treatment for high blood pressure and kidney issues, plus education using these models to see if it improves understanding and management of their condition.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: 3D Kidney model enhanced patient educationExperimental Treatment1 Intervention
patient education with 3D model
Group II: Standard clinical care/TAUActive Control1 Intervention
standard clinician-led patient education

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hilary L Surratt, PhD

Lead Sponsor

Trials
4
Recruited
680+

University of Kentucky

Collaborator

Trials
198
Recruited
224,000+

Findings from Research

Patient education is crucial for improving outcomes in individuals with progressive kidney disease, but various barriers such as low health literacy, limited information availability, and provider time constraints hinder its implementation in the U.S.
Innovative educational strategies, including self-management support and community engagement, show promise in enhancing patient education, particularly for those with advanced kidney disease, despite challenges in evaluating their effectiveness.
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care.Narva, AS., Norton, JM., Boulware, LE.[2022]

References

Novel Volumetric and Morphological Parameters Derived from Three-dimensional Virtual Modeling to Improve Comprehension of Tumor's Anatomy in Patients with Renal Cancer. [2022]
Physical models of renal malignancies using standard cross-sectional imaging and 3-dimensional printers: a pilot study. [2022]
[Intervention planning in modern renal surgery]. [2023]
Multicentre, randomised, economic evaluation of a web-based interactive education platform, simple or enhanced, for patients with end-stage renal disease: the PIC-R trial protocol. [2023]
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. [2022]
The development of a virtual 3D model of the renal corpuscle from serial histological sections for E-learning environments. [2015]
Usefulness of personalized three-dimensional printed model on the satisfaction of preoperative education for patients undergoing robot-assisted partial nephrectomy and their families. [2019]
Building a Web-Augmented Reality application for demonstration of kidney pathology for veterinary education. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security